Page 571 - Read Online

Chen et al. Plast Aesthet Res 2020;7:49 I http://dx.doi.org/10.20517/2347-9264.2020.28 Page 9 of 12

Performed data acquisition, as well as provided administrative, technical, and material support: Chen YC,
Chang CH

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by Ministry of Science and Technology (MOST-108-2314-B-418-010-MY3,
MOST 109-2314-B-418-002-MY3) and Far Eastern Memorial Hospital (FEMH -2019-C-004, FEMH-
2019-C-080, FEMH-2017-C-007, FEMH-2017-C-046).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Aigner T, Stove J. Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in
cartilage repair. Adv Drug Deliv Rev 2003;55:1569-93.
2. Mow VC, Setton LA. Mechanical properties of normal and osteoarthritic articular cartilage. In: Brandt KD, Doherty M, Lohmander LS,
editors. Osteoarthritis. Oxford: Oxford University Press; 1998. pp. 108-22.
3. Mauck LR, Burdick JA. Engineering cartilage tissue. In: Pallua N, Suschek CV, editors. Tissue Engineering, from lab to clinic. UK:
Springer-Verlag Berlin Heidelberg; 2011. pp. 493-520.
4. Bastiaansen-Jenniskens YM, Koevoet W, de Bart AC, van der Linden JC, Zuurmond AM, et al. Contribution of collagen network features
to functional properties of engineered cartilage. Osteoarthritis Cartilage 2008;16:359-66.
5. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006;20:3-25.
6. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey
data. Arthritis Rheum 2009;60:3546-53.
7. Fransen M, Bridgett L, March L, Hoy D, Penserga E, et al. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis 2011;14:113-21.
8. Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2013;39:1-19.
9. Jo CH, Chai JW, Jeong EC, Oh S, Shin JS, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of
the Knee: a 2-year follow-up study. Am J Sports Med 2017;45:2774-83.
10. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
11. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue
inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta
1990;22:366-78.
12. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with
osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-9.
13. Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv
Musculoskelet Dis 2013;5:77-94.
14. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of
osteoarthritis. Nat Rev Rheumatol 2011;7:33-42.
15. Harris DJ, Flanigan DC. Management of knee articular cartilage injuries. In: Dragoo JL, editor. Modern Arthroscopy. InTech; 2011. pp.
103-28.
16. Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci 2013;5:30-8.
17. Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev
Rheumatol 2019;15:77-90.